Casandra
Casandra Test Code QD90581Version 1 (DRAFT)
Performing Lab
JAK2 V617F Mutation Analysis
Clinical Use
Order TestUse
Detection of the JAK2 V617F mutation supports diagnosis of myeloproliferative neoplasms such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis, and aids in patient management decisions. Quantitatively assessing allele burden may help guide therapy and disease monitoring.
Special Instructions
Not provided.
Limitations
This test detects only the V617F mutation in exon 14 of JAK2 and does not detect mutations in other regions such as exon 12. Negative results do not exclude the presence of other JAK2 or MPN-associated mutations.
Test Details
Methodology
PCR-based (PCR)
Biomarkers
JAK2
GeneSNV/Indel • Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
5-7 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
4 mL
Minimum Volume
3 mL
Container
Lavender EDTA tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
Related Tests
Other tests from different labs that may be relevant
JAK2 V617F Mutation Analysis
MPLN
JAK2V617F Mutation Analysis, Quantitative
Labcorp
JAK2 V617F Mutation Analysis - Quantitative
NeoGenomics
JAK2 (V617F) Mutation by ddPCR, Qualitative
ARUP Laboratories
JAK2V617F Mutation Analysis, Quantitative, With Reflex to JAK2 Exon 12-15 Mutation Analysis by NGS
Labcorp
JAK2V617F Mutation Analysis, Qualitative
Labcorp
JAK2 V617F Mutation Analysis by NGS
NeoGenomics
JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to CALR (Calreticulin) Exon 9 Mutation Analysis by PCR and MPL Mutation Detection
ARUP Laboratories
JAK2 (V617F) Mutation by ddPCR, Qualitative With Reflex to JAK2 Exon 12-Mutation Analysis by PCR
ARUP Laboratories
MPN JAK2 V617F with Sequential Reflex to JAK2 Exon 12-15, CALR, and MPL
NeoGenomics